BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15259908)

  • 1. IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients.
    Marchetti G; Meroni L; Molteni C; Taskaris G; Gazzola L; Galli M; Clerici M; Moroni M; Franzetti F; Gori A
    Antivir Ther; 2004 Jun; 9(3):447-52. PubMed ID: 15259908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis.
    Marchetti G; Riva A; Cesari M; Bellistrì GM; Gianelli E; Casabianca A; Orlandi C; Magnani M; Meroni L; d'Arminio Monforte A; Mussini C; Cossarizza A; Galli M; Gori A;
    HIV Med; 2009 Aug; 10(7):422-31. PubMed ID: 19459995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
    AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation.
    Koesters SA; Alimonti JB; Wachihi C; Matu L; Anzala O; Kimani J; Embree JE; Plummer FA; Fowke KR
    Eur J Immunol; 2006 Feb; 36(2):336-44. PubMed ID: 16421946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients.
    Colle JH; Moreau JL; Fontanet A; Lambotte O; Delfraissy JF; Thèze J
    AIDS; 2007 Jan; 21(1):101-3. PubMed ID: 17148974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
    Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
    J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
    Marchetti G; Meroni L; Varchetta S; Terzieva V; Bandera A; Manganaro D; Molteni C; Trabattoni D; Fossati S; Clerici M; Galli M; Moroni M; Franzetti F; Gori A
    J Infect Dis; 2002 Sep; 186(5):606-16. PubMed ID: 12195347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).
    Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Delfraissy JF; Thèze J
    Clin Exp Immunol; 2006 Mar; 143(3):398-403. PubMed ID: 16487237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.
    Sasson SC; Zaunders JJ; Zanetti G; King EM; Merlin KM; Smith DE; Stanley KK; Cooper DA; Kelleher AD
    J Infect Dis; 2006 Feb; 193(4):505-14. PubMed ID: 16425129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
    Mitsuyasu R; Gelman R; Cherng DW; Landay A; Fahey J; Reichman R; Erice A; Bucy RP; Kilby JM; Lederman MM; Hamilton CD; Lertora J; White BL; Tebas P; Duliege AM; Pollard RB;
    Arch Intern Med; 2007 Mar; 167(6):597-605. PubMed ID: 17389292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M; De Santis W; Carello R; Leti W; Esposito A; Isgrò A; Fimiani C; Sirianni MC; Mezzaroma I; Aiuti F
    AIDS; 2006 Oct; 20(16):2033-41. PubMed ID: 17053349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells.
    Vranjkovic A; Crawley AM; Gee K; Kumar A; Angel JB
    Int Immunol; 2007 Dec; 19(12):1329-39. PubMed ID: 17956896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunological effects of interleukin 2 therapy in HIV+ patients.
    De Paoli P
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):243-9. PubMed ID: 11059640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of therapeutic use of interleukin-2 in HIV infection].
    Knysz B; Gasiorowski J; Inglot M; Rymer W; Szymczak A; Gładysz A
    Przegl Epidemiol; 2002; 56(4):587-93. PubMed ID: 12666584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.